• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form SC 13G/A filed by Afya Limited

    11/14/24 4:21:17 PM ET
    $AFYA
    Other Consumer Services
    Real Estate
    Get the next $AFYA alert in real time by email
    SC 13G/A 1 dp220674_sc13ga-vanessa4.htm FORM SC 13G/A

     

     

     

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    SCHEDULE 13G/A

     

    Under the Securities Exchange Act of 1934

     

    (Amendment No. 4)*

     

    Afya Limited
    (Name of Issuer)
     
    Class A Common Shares, par value $0.00005 per share
    (Title of Class of Securities)
     
    G01125 106
    (CUSIP Number)
     
    September 30, 2024
    (Date of Event which Requires Filing of this Statement)

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

     

    ☒Rule 13d-1(b)

     

    ☐Rule 13d-1(c)

     

    ☐Rule 13d-1(d)

     

    * The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

     

    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     

     

     

     1

    NAME OF REPORTING PERSON

     

    Vanessa Tavares Esteves

    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ☐
    (b) ☐
    3

    SEC USE ONLY

     

    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Brazil

    NUMBER OF
    SHARES BENEFICIALLY OWNED
    BY EACH REPORTING PERSON
    WITH
    5

    SOLE VOTING POWER

     

    1,435,440

    6

    SHARED VOTING POWER

     

    ____

    7

    SOLE DISPOSITIVE POWER

     

    1,435,440

    8

    SHARED DISPOSITIVE POWER

     

    ____

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    1,435,440 (1)

    10

    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES ☐

     

    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    3.1% (2)

    12

    TYPE OF REPORTING PERSON

     

    IN

           

     

    (1)Consists of 1,435,440 Class A common shares held of record by VTE B Ventures Ltd., a wholly-owned subsidiary of VTE Capital Ventures Ltd., which is, in turn, wholly-owned by Vanessa Tavares Esteves.

    (2)Represents the quotient obtained by dividing (a) the number of Class A common shares beneficially owned by the Reporting Person as set forth in Row 9 by (b) 46,645,169 Class A common shares outstanding as of November 13, 2024, as reported by the Issuer to the Reporting Person.

     

     

     

     1

    NAME OF REPORTING PERSON

     

    VTE Capital Ventures Ltd

    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ☐
    (b) ☐
    3

    SEC USE ONLY

     

    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    British Virgin Islands

    NUMBER OF
    SHARES BENEFICIALLY OWNED
    BY EACH REPORTING PERSON
    WITH
    5

    SOLE VOTING POWER

     

    ___ 

    6

    SHARED VOTING POWER

     

    0

    7

    SOLE DISPOSITIVE POWER

     

    ___

    8

    SHARED DISPOSITIVE POWER

     

    0

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    0

    10

    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES ☐

     

    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    0

    12

    TYPE OF REPORTING PERSON

     

    CO

     

     

     

     1

    NAME OF REPORTING PERSON

     

    VTE B Ventures Limited

    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ☐
    (b) ☐
    3

    SEC USE ONLY

     

    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    British Virgin Islands

    NUMBER OF
    SHARES BENEFICIALLY OWNED
    BY EACH REPORTING PERSON
    WITH
    5

    SOLE VOTING POWER

     

    ___

    6

    SHARED VOTING POWER

     

    1,435,440

    7

    SOLE DISPOSITIVE POWER

     

    ___

    8

    SHARED DISPOSITIVE POWER

     

    1,435,440

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    1,435,440 (1)

    10

    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES ☐

     

    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    3.1% (2)

    12

    TYPE OF REPORTING PERSON

     

    CO

           

     

    (1)Consists of 1,435,440 Class A common shares held of record by VTE B Ventures Ltd., a wholly-owned subsidiary of VTE Capital Ventures Ltd., which is, in turn, wholly-owned by Vanessa Tavares Esteves.

    (2)Represents the quotient obtained by dividing (a) the number of Class A common shares beneficially owned by the Reporting Person as set forth in Row 9 by (b) 46,645,169 Class A common shares outstanding as of November 13, 2024, as reported by the Issuer to the Reporting Person.

     

     

     

    ITEM 1.(a)        Name of Issuer: Afya Limited (the “Issuer”)

     

    (b)Address of Issuer’s Principal Executive Offices:
    Alameda Oscar Niemeyer, No. 119, Salas 502, 504, 1,501 and 1,503
    Vila da Serra, Nova Lima, Minas Gerais, Brazil

     

    ITEM 2.(a)        Name of Person Filing:

     

    This Schedule 13G is being filed by (i) Vanessa Tavares Esteves; (ii) VTE Capital Ventures Ltd. and (iii) VTE B Ventures Ltd. (each, a “Reporting Person” and collectively the “Reporting Persons”). Vanessa Tavares Esteves is party to an amended and restated shareholders agreement (the “Amended and Restated Shareholders Agreement”), dated May 4, 2022, between Nicolau Carvalho Esteves, Rosângela de Oliveira Tavares Esteves, Bertelsmann SE & Co. KGaA, NRE Capital Ventures Limited, NRE B Ventures Limited, and Renato Tavares Esteves, Lílian Tavares Esteves de Carvalho and Vanessa Tavares Esteves, solely as successors.

     

    The Reporting Persons are filing this Schedule 13G jointly considering that VTE B Ventures Ltd. is wholly-owned by VTE Capital Ventures Ltd., and VTE Capital Ventures Ltd. is wholly-owned by Vanessa Tavares Esteves. Each of the Reporting Persons disclaims beneficial ownership with respect to any shares of stock owned by the other Reporting Persons. The Reporting Persons have entered into a Joint Filing Agreement, a copy of which is filed with this Schedule 13G as Exhibit A, pursuant to which the Reporting Persons have agreed to file this Schedule 13G jointly in accordance with the provisions of Rule 13d-1(k) of the Act.

     

    (b)Address of Principal Business Office, or if None, Residence:

     

    The principal office and business address of Vanessa Tavares Esteves is Alameda Oscar Niemeyer, No. 119, Salas 502, 504, 1,501 and 1,503, Vila da Serra - Nova Lima, Minas Gerais, Brazil.

     

    The principal office and business address of VTE Capital Ventures Ltd. is Craigmuir Chambers, Road Town, Tortola, BVI VG1110.

     

    The principal office and business address of VTE B Ventures Ltd. is Craigmuir Chambers, Road Town, Tortola, BVI VG1110.

     

    (c)Citizenship or Place of Organization:

     

    See row 4 of the cover pages to this Schedule 13G.

     

    (d)Title of Class of Securities:

     

    This Schedule 13G relates to the Issuer’s Class A common shares, par value $0.00005 per share.

     

    (e)CUSIP Number:

     

    G01125 106

     

    ITEM 3.IF THIS STATEMENT IS FILED PURSUANT TO SS.240.13D-1(B) OR 240.13D-2(B) OR (C), CHECK WHETHER THE PERSON FILING IS A:

     

    Not Applicable.

     

     

     

    ITEM 4.OWNERSHIP.

     

    All ownership percentages assume that there are 46,645,169 Class A common shares outstanding.

     

    The information set forth in Item 2 above is incorporated by reference for each Reporting Person.

     

    (a) Amount beneficially owned:

    See row 9 of the cover sheet of each Reporting Person.

    (b) Percent of class:

    See row 11 of the cover sheet of each Reporting Person.

    (c) Number of shares as to which the person has:

    (i) Sole power to vote or to direct the vote:

    See row 5 of the cover sheet of each Reporting Person.

    (ii) Shared power to vote or to direct the vote:

    See row 6 of the cover sheet of each Reporting Person.

    (iii) Sole power to dispose or to direct the disposition of:

    See row 7 of the cover sheet of each Reporting Person.

    (iv) Shared power to dispose or to direct the disposition of:

    See row 8 of the cover sheet of each Reporting Person.

     

    ITEM 5.OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS.

     

    The Reporting Persons have ceased to hold over 5% of the shares.

     

    ITEM 6.OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON.

     

    Not Applicable.

     

    ITEM 7.IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY.

     

    Not Applicable.

     

    ITEM 8.IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP.

     

    Not Applicable.

     

    ITEM 9.NOTICE OF DISSOLUTION OF GROUP.

     

    Not Applicable.

     

    ITEM 10.CERTIFICATIONS.

     

    Not Applicable.

     

     

     

    SIGNATURE

     

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     

    Dated: November 14, 2024

     

      Vanessa Tavares Esteves
       
       
      By: /s/ Vanessa Tavares Esteves
      Name: Vanessa Tavares Esteves

     

     

      VTE Capital Ventures Limited
       
       
      By: /s/ Vanessa Tavares Esteves
      Name: Vanessa Tavares Esteves
      Title: Director

     

     

      VTE B Ventures Limited
       
       
      By: /s/ Vanessa Tavares Esteves
      Name: Vanessa Tavares Esteves
      Title: Director

     

     

     

    Exhibit A

     

    SCHEDULE 13G

     

    JOINT FILING AGREEMENT

     

    In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the undersigned agree to the joint filing on behalf of each of them of a statement on Schedule 13G (including amendments thereto) with respect to the Class A common shares of Afya Limited and further agree that this Joint Filing Agreement shall be included as an exhibit to such joint filings.

     

    The undersigned further agree that each party hereto is responsible for the timely filing of such Schedule 13G and any amendments thereto, and for the completeness and accuracy of the information concerning such party contained therein; provided, however, that no party is responsible for the completeness or accuracy of the information concerning any other party making the filing, unless such party knows or has reason to believe that such information is inaccurate.

     

    IN WITNESS WHEREOF, the parties have executed this Joint Filing Agreement on November 14, 2024.

     

      Vanessa Tavares Esteves
       
       
      By: /s/ Vanessa Tavares Esteves
      Name: Vanessa Tavares Esteves

     

     

      VTE Capital Ventures Limited
       
       
      By: /s/ Vanessa Tavares Esteves
      Name: Vanessa Tavares Esteves
      Title: Director

     

     

      VTE B Ventures Limited
       
       
      By: /s/ Vanessa Tavares Esteves
      Name: Vanessa Tavares Esteves
      Title: Director

     

     

    Get the next $AFYA alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $AFYA

    DatePrice TargetRatingAnalyst
    3/11/2025$19.00 → $17.00Equal-Weight → Underweight
    Morgan Stanley
    1/31/2025$18.00 → $15.00Neutral → Sell
    Citigroup
    12/3/2024$16.00Sell
    Goldman
    8/30/2024$19.50Neutral
    UBS
    1/29/2024$23.00Neutral
    Citigroup
    1/22/2024$20.50 → $23.00Overweight → Equal-Weight
    Morgan Stanley
    10/13/2023$16.50 → $20.50Equal-Weight → Overweight
    Morgan Stanley
    4/8/2022$18.00 → $19.00Neutral → Outperform
    Credit Suisse
    More analyst ratings

    $AFYA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Afya Limited

      SC 13G/A - Afya Ltd (0001771007) (Subject)

      11/14/24 5:15:03 PM ET
      $AFYA
      Other Consumer Services
      Real Estate
    • Amendment: SEC Form SC 13G/A filed by Afya Limited

      SC 13G/A - Afya Ltd (0001771007) (Subject)

      11/14/24 4:21:17 PM ET
      $AFYA
      Other Consumer Services
      Real Estate
    • Amendment: SEC Form SC 13G/A filed by Afya Limited

      SC 13G/A - Afya Ltd (0001771007) (Subject)

      11/14/24 4:18:15 PM ET
      $AFYA
      Other Consumer Services
      Real Estate

    $AFYA
    Financials

    Live finance-specific insights

    See more
    • Afya Limited Announces First-Quarter 2025 Financial Results

      Impressive Adjusted EBITDA Margin Expansion and Cash Generation Full Year 2025 Guidance Reaffirmed Afya Limited (NASDAQ:AFYA, B3: A2FY34)) ("Afya" or the "Company"), the leading medical education group and medical practice solutions provider in Brazil, reported today its financial and operating results for the three-month period ended March 31, 2025 (first quarter 2025). Financial results are expressed in Brazilian Reais and are presented in accordance with International Financial Reporting Standards (IFRS). First Quarter 2025 Highlights 1Q25 Net Revenue increased 16.4% YoY to R$936.4 million. Net Revenue excluding acquisitions increased 10.9%, reaching R$891.5 million. 1Q25 Adjusted

      5/8/25 8:11:00 PM ET
      $AFYA
      Other Consumer Services
      Real Estate
    • Afya Limited Announces Fourth Quarter and Full-Year 2024 Financial Results

      Impressive Adjusted EBITDA Margin Expansion Expressive Cash Generation First Dividend Announcement Afya Limited (NASDAQ:AFYA, B3: A2FY34)) ("Afya" or the "Company"), the leading medical education group and medical practice solutions provider in Brazil, reported today its financial and operating results for the fourth quarter and full-year period ended December 31, 2024. Financial results are expressed in Brazilian Reais and are presented in accordance with International Financial Reporting Standards (IFRS). Fourth Quarter 2024 Highlights 4Q24 Net Revenue increased 16.3% YoY to R$849.0 million. Net Revenue excluding acquisitions increased 12.0%, reaching R$817.8 million. 4Q24 Adjust

      3/13/25 5:45:00 PM ET
      $AFYA
      Other Consumer Services
      Real Estate
    • Afya Limited Announces First Dividend Distribution of R$129.8 Million

      Afya Limited (NASDAQ:AFYA, B3: A2FY34)) ("Afya" or the "Company"), Brazil's leading medical education group and provider of medical practice solutions, announced that its board of directors (the "Board") approved its first distribution of a cash dividend. On March 12, 2025, Afya's Board declared a cash dividend of R$129.8 million, representing 20% of the Company's consolidated net income of R$648.9 million for the year ended December 31, 2024. This amounts to a dividend per share (DPS) of R$1.348923, payable in U.S. dollars on April 4, 2025, to shareholders of record as of the close of business on March 26, 2025. The payment will be made at the exchange rate (PTAX) published on March 13, 2

      3/13/25 4:57:00 PM ET
      $AFYA
      Other Consumer Services
      Real Estate

    $AFYA
    Leadership Updates

    Live Leadership Updates

    See more
    • Afya Limited Announces that Whitebook was ranked as one of the 10 Top Apps in Brazil by Consumer Spend in 2020

      NOVA LIMA, Brazil and MINAS GERAIS, Brazil, Jan. 15, 2021 (GLOBE NEWSWIRE) -- Afya Limited, or Afya (Nasdaq: AFYA), today announces that its clinical decision software, WhiteBook, an app created by PEBMED, was ranked as one of the 10 Top Apps in Brazil by consumer spend in 2020 for the fifth year in a row. App Annie conducted the study, a website specialized in app analytics and app market data that combined data from iOS and Google Play that evaluates more than 8 million mobile app per year. In the top ten WhiteBook was among great apps such as Tinder, YouTube, Netflix, TikTok and others. Whitebook is a mobile and web application software that helps doctors and medical students to make

      1/15/21 8:55:10 AM ET
      $AFYA
      Other Consumer Services
      Real Estate

    $AFYA
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Afya Limited Announces First-Quarter 2025 Financial Results

      Impressive Adjusted EBITDA Margin Expansion and Cash Generation Full Year 2025 Guidance Reaffirmed Afya Limited (NASDAQ:AFYA, B3: A2FY34)) ("Afya" or the "Company"), the leading medical education group and medical practice solutions provider in Brazil, reported today its financial and operating results for the three-month period ended March 31, 2025 (first quarter 2025). Financial results are expressed in Brazilian Reais and are presented in accordance with International Financial Reporting Standards (IFRS). First Quarter 2025 Highlights 1Q25 Net Revenue increased 16.4% YoY to R$936.4 million. Net Revenue excluding acquisitions increased 10.9%, reaching R$891.5 million. 1Q25 Adjusted

      5/8/25 8:11:00 PM ET
      $AFYA
      Other Consumer Services
      Real Estate
    • Afya Limited Announces Closing of the Acquisition of FACULDADE ÚNICA DE CONTAGEM

      Afya Limited (NASDAQ:AFYA, B3: A2FY34)) ("Afya" or the "Company"), the leading medical education group and medical practice solutions provider in Brazil, in addition to the Press Release released by the company on December 19th, 2024, announced today the closing of its acquisition, through its wholly-owned subsidiary Afya Participações S.A., of 100% of the total share capital of Faculdade Masterclass Ltda. ("FACULDADE ÚNICA DE CONTAGEM" or "FUNIC"), located in Contagem, a city in the metropolitan area of Belo Horizonte, the capital of the State of Minas Gerais. The acquisition contributes 60 medical school seats to Afya. FUNIC is pre-operational, with leased real estate prepared for a medi

      5/7/25 5:27:00 PM ET
      $AFYA
      Other Consumer Services
      Real Estate
    • Afya Limited Announces Fourth Quarter and Full-Year 2024 Financial Results

      Impressive Adjusted EBITDA Margin Expansion Expressive Cash Generation First Dividend Announcement Afya Limited (NASDAQ:AFYA, B3: A2FY34)) ("Afya" or the "Company"), the leading medical education group and medical practice solutions provider in Brazil, reported today its financial and operating results for the fourth quarter and full-year period ended December 31, 2024. Financial results are expressed in Brazilian Reais and are presented in accordance with International Financial Reporting Standards (IFRS). Fourth Quarter 2024 Highlights 4Q24 Net Revenue increased 16.3% YoY to R$849.0 million. Net Revenue excluding acquisitions increased 12.0%, reaching R$817.8 million. 4Q24 Adjust

      3/13/25 5:45:00 PM ET
      $AFYA
      Other Consumer Services
      Real Estate

    $AFYA
    SEC Filings

    See more
    • SEC Form 6-K filed by Afya Limited

      6-K - Afya Ltd (0001771007) (Filer)

      5/8/25 4:13:04 PM ET
      $AFYA
      Other Consumer Services
      Real Estate
    • SEC Form 6-K filed by Afya Limited

      6-K - Afya Ltd (0001771007) (Filer)

      5/8/25 4:09:46 PM ET
      $AFYA
      Other Consumer Services
      Real Estate
    • SEC Form 6-K filed by Afya Limited

      6-K - Afya Ltd (0001771007) (Filer)

      5/7/25 4:18:35 PM ET
      $AFYA
      Other Consumer Services
      Real Estate

    $AFYA
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Afya downgraded by Morgan Stanley with a new price target

      Morgan Stanley downgraded Afya from Equal-Weight to Underweight and set a new price target of $17.00 from $19.00 previously

      3/11/25 7:14:11 AM ET
      $AFYA
      Other Consumer Services
      Real Estate
    • Afya downgraded by Citigroup with a new price target

      Citigroup downgraded Afya from Neutral to Sell and set a new price target of $15.00 from $18.00 previously

      1/31/25 8:29:57 AM ET
      $AFYA
      Other Consumer Services
      Real Estate
    • Goldman initiated coverage on Afya with a new price target

      Goldman initiated coverage of Afya with a rating of Sell and set a new price target of $16.00

      12/3/24 8:02:22 AM ET
      $AFYA
      Other Consumer Services
      Real Estate